Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 6Keratosis, Actinic 5Brain Neoplasms 5Glioma 4Skin Diseases 2Precancerous Conditions 2Neoplasms 2Carcinoma, Basal Cell 2Squamous Cell Carcinoma of Head and Neck 1Skull Base Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Oligodendroglioma 1Non-Melanoma Skin Cancer (NMSC) 1Mouth Neoplasms 1Meningioma 1Lichen Planus, Oral 1Leukoplakia, Oral 1Kidney Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma in Situ 1Breast Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 14Nivolumab 11Ipilimumab 10cabozantinib 6Axitinib 6belzutifan 5Radiosurgery 5atezolizumab 4Sunitinib 4palbociclib 3lenvatinib 3Surveys and Questionnaires 3Radiotherapy 3Pluvicto 3Everolimus 3Blood Specimen Collection 3Biopsy 3zimberelimab 2pazopanib 2cemiplimab 2Therapeutics 2Methods 2Magnetic Resonance Spectroscopy 2Irinotecan 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2trebananib 1toripalimab 1tocilizumab 1temsirolimus 1spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Aminolevulinic Acid × 1 year × Clear all
NCT06948552 2026-04-01

Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA

Henry Ford Health System

Phase 2 Recruiting
10 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡